Why the study?
Does milrinone improve outcomes in patients with cardiogenic shock compared to dobutamine?
Population
Patients with cardiogenic shock
Comparison
Milrinone vs dobutamine
Authors
Loading...
Either agent may be selected in cardiogenic shock; confirms similar efficacy in this RCT.
Does milrinone improve outcomes in patients with cardiogenic shock compared to dobutamine?
Milrinone and dobutamine demonstrate no significant difference in efficacy for the treatment of cardiogenic shock.
Mathew et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: